4 results  1 of 1 

1 Lamotrigine, an antiepileptic drug, inhibits 5-HT3 receptor currents in NCB-20 neuroblastoma cells
Ki Jung Kim, Seung Hyun Jeun, Ki-Wug Sung
Korean J Physiol Pharmacol.2017;21(2):169-177.   Published online 2017 February 21     DOI: http://dx.doi.org/10.4196/kjpp.2017.21.2.169
      
2 Association of 5-HT3B Receptor Gene Polymorphisms with the Efficacy of Ondansetron for Postoperative Nausea and Vomiting
Min-Soo Kim, Jeong-Rim Lee, Eun-Mi Choi, Eun Ho Kim, Seung Ho Choi
Yonsei Med J.2015;56(5):1415-1420.   Published online 2015 July 29     DOI: http://dx.doi.org/10.3349/ymj.2015.56.5.1415
      
3 Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer
Satoe Fujiwara, Yoshito Terai, Satoshi Tsunetoh, Hiroshi Sasaki, Masanori Kanemura, Masahide Ohmichi
J Gynecol Oncol.2015;26(4):311-319.   Published online 2015 July 20     DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.311
      
4 Effects of Palonosetron, a 5-HT3 Receptor Antagonist, on Mechanical Allodynia in a Rat Model of Postoperative Pain
Ki Tae Jung, Myung Ha Yoon, Hyun Young Lee, Bo Yeon Yu, Dong Kyu Kim, Kyung Joon Lim
Korean J Pain.2013;26(2):125-129.   Published online 2013 April 3     DOI: http://dx.doi.org/10.3344/kjp.2013.26.2.125
      

 1 of 1